Ketamine appears to be everywhere, from nightclubs to psychiatric clinics. Some users say they take ketamine every two weeks because of depression, as prescribed by their doctors. He is not alone. More and more Americans are turning to ketamine for relief in the struggle for mental health.
However, the New York Times reportedly reportedly reportedly reportedly told people that masks were taking so many ketamines during last year's presidential election, that he was causing bladder problems, a known symptom of chronic ketamine use. Reported drug reports of masks provide a window into the growing popularity of ketamine in the United States, from medical to abusive – and the paradox that its popularity presents.
Ketamine, both anesthetic and hallucinogenic, was first synthesized in the 1960s and has been used for a long time in surgery and veterinary medicine. Recently, significant efficacy has been shown to alleviate depression symptoms, particularly in treatment-resistant populations. Clinics that administer this drug must be legally approved by the government to provide intravenous infusions – is becoming more common. The Food and Drug Administration approved the first ketamine-derived nasal spray for depression in 2019.
Meanwhile, it appears that more Americans are using ketamine on recreational and non-medical supervision, as highlighted in a Times report claiming that masks mix ketamine with other drugs. Chronic misuse can be at risk of serious physical and mental health effects, ranging from kidney and liver damage to memory loss and delusions.
“Ketamine has an absolute role in helping people with depression and suicidal thoughts,” says Dr. Kevin Yang, a resident psychiatry physician at the University of California and the University of San Diego. “At the same time, that doesn't mean it's safe and effective for everyone.”
According to a study co-authored by Yang and published earlier this year, the percentage of Americans who reported using ketamine within the past year, which grew by 82% in 2020 from 2015 to 2019, fell briefly in 2020, but perhaps because access to pandemic people access to drugs, both people from 2021 to 2022 had an additional 40% increase in 2021, and both people from 2021 to 2022, who proposed that no ones from 2021 to 2022, and both people from 2021 to 2022, who proposed that no ones from 2021 to 2022, were up 40% in 2021, according to a study published earlier this year. We are looking for more people who are looking for ketamine for clinical purposes and use it in recreational purposes. The total number of people taking ketamine is still small. It is about 0.28% of the population in 2022, which may be a shortage as it doesn't always tell the truth in drug use surveys.
There is other evidence suggesting that more people are taking ketamine recreationally. Yang's study found that ketamine use is the most increase among white people and people with university degrees, and users reported taking it more frequently in combination with other recreational medications such as ecstasy and cocaine.
According to a 2023 survey led by Joseph Paramer of New York University, ketamine drug attacks nationwide increased from 55 in 2017 to 247 in 2022. Experts believe that most recreational ketamines are produced illegally, but the number of legitimate ketamine prescriptions that have been decoupled, that is, lost or stolen, has risen, as a 2024 analysis by Paramar and his colleagues discovered. The topic of ketamine's popularity and its persistence in certain club cultures that first appeared in the '80s confirms the location of counterculture.
We cannot know the reality behind Musk's official statement and anonymous reports of his use of ketamine. The Times reports that people close to masks are worried that the therapeutic use of ketamine has become recreational. Musk immediately rejected the Times report. However, the drug coexists as a therapeutic drug and a narcotic, and the line between the two may be blurry.
Yang said people should not try to self-treat ketamine. You need to take that risk seriously. This is what you need to know.
How to think about ketamine as it grows in popularity
Ketamine has been mainstream for years with its fringe. It has been booming as a party drug for decades in the 80s and 90s. In most cases, ketamine was carefully viewed by mainstream scientists. However, in 2000, the first major study was published to demonstrate its value in the treatment of depression. However, more and more over the past decade, ketamine has begun to gain more acceptance due to consistently impressive research results. Research has found that for some patients, ketamine may begin to relieve depression several hours after treatment or other medication has failed. As published on VOX, the testimony of patients with rapid improvement in depression is compelling.
The advantages identified in clinical studies have opened a larger market for this substance. Johnson & Johnson has developed its own ketamine-derived treatment for the first 2019 FDA-approved ketamine-derived treatment of depression (sold as a nasal spray called sprabat). Spravato's monthly prescriptions doubled from the beginning of 2023 to October 2024. People can also receive traditional ketamine IV for treatment. The business is also booming. Today there are 1,200-1,500.
This expanded access could be helpful for the 21 million Americans experiencing major depression. Ketamine and escamine appear to have a strong anti-suppressive effect as long as they are used under consultation and supervision with a doctor. A 2023 meta-analysis of related studies found that in many clinical trials most patients reported significant improvement in symptoms within 24 hours. It is primarily recommended for people who have not improved their depression after attempting other treatments, or for those with severe suicidal thoughts who need to rapidly improve their symptoms to avoid a life-threatening emergency.
However, providers will also screen potential patients for current substance use issues for very important reasons. The risk of ketamine abuse is real.
When ingested outside the clinical setting, ketamine is often consumed as a pill or powder and mixed with drinks. A recent study found that over half of patients who tried to take ketamine for depression at home were taking it intentionally or mistakenly over the prescribed amount. Users can also develop tolerance over time. This increases the risk that people take stronger and stronger doses and feel the same effect.

Scientists have discovered that people who use ketamine can rely on it, especially with frequent and advanced uses. Without drugs they become irritated or anxious and experience other withdrawal symptoms. Although not more potent than nicotine or opioids, its addictive quality is an important distinction from other hallucinogens such as psilocybin, which are also used in experimental environments for mental health needs and are less likely to form habits.
Ketamine therapy may also require maintenance doses, and adjusting long-term use to prevent addiction is another reason why medical supervision is so important. There is limited evidence that most people using ketamine in clinical settings do not abuse it. However, ketamine use for depression remains very new and still growing, so it is an important risk to be aware of. Johnson & Johnson urges patients to be aware of possible misuse of Splabat.
The line between genuine therapeutic use and abuse becomes clear when every other weekly treatment in the clinic changes to normal home-at-home practices. In particular, it includes obtaining drugs from illegal sources where purity is not guaranteed. Street ketamine is usually merely the drug itself and is illegally produced and sold. However, Dr. Navalun Dasgupta, who oversees the University of North Carolina's Street Drug Analysis Lab, said he has noticed a recent increase in samples in which ketamine is combined with other substances.
By itself, ketamine is used in a short term in excess, and can lead to nausea and high blood pressure along with hallucinations and hallucinations, hallucinations and “bad trips.” Long-term abuse can lead to problems with bladder and urinary tract in a person, making it difficult to urinate. This is the type of problem that masks explained to private people, according to the era. People who are chronically abusing ketamine can also experience delusions, memory loss, and shortened attention.
The potential for ketamine in a clinical setting is exciting. However, their use comes with risks and sufficient people are not aware of them. A recent survey from the UK found that many people who took ketamine don't know it's addictive.
That's possible. Ketamine is not something you should experiment with yourself. Yang told me that there are all sorts of safety checks for patients in the clinic. Ketamine “has been shown to be absolutely extremely effective,” he said. He said “under the supervision of a clinician” before adding a very important qualifier.